AIDS In The USA: People, Papers, And Funding

“Better late than never,” one might say about the U.S. federal government’s response to AIDS, first identified in 1981. Only in the past few years has the government moved aggressively to fund the battle against the epidemic. Today, al- though federal funding has greatly increased, many continue to believe that it is still below what it should be. In the spring of 1987, AIDS researcher and immunochemist Paul Naylor of George Washington University called for a tripling of the

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the spring of 1987, AIDS researcher and immunochemist Paul Naylor of George Washington University called for a tripling of the then-current research budget for AIDS, which stood at close to half a billion dollars. That goal may now be in sight. Federal outlays for fiscal year 1988 will likely approach between $1 billion and $1.5 billion, which is the appropriated sum. And the president’s request for fiscal year 1989 is for $2.2 billion. Naylor now says, “We are beginning to approach levels of spending that could be considered maximally effective, given the available talent pool of researchers and technicians.” But he quickly adds, “It is important, however, that the government continue its commitment for more than the short term.”

The accompanying chart brings together three sets of data: (a) the number of diagnosed cases of AIDS per year since 1982; (b) the number of AIDS articles with at least ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • David Pendlebury

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours